Calcitonin clinical trials

Explore recruiting calcitonin clinical trials.

Recruiting calcitonin studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Calcitonin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity secondary to craniopharyngioma in children aged 12 to 17 years

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Exploring Eptinezumab: Unveiling Peripheral and Central Mechanisms of Action and Searching for Biomarkers of Patient Response (EUPHORIA Study)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

PIONEER TEENS Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes.

Greece, Czechia, Portugal, Romania, Austria, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-term safety and efficacy of semaglutide s.c. once-weekly on weight management in children and adolescents (aged 6 to <18 years) with obesity or overweight

Belgium, Portugal, Sweden, Germany, Austria, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Calcitonin trials by city

Calcitonin in Toronto Calcitonin in Vancouver Calcitonin in Montreal Calcitonin in Calgary Calcitonin in Edmonton Calcitonin in Ottawa Calcitonin in Winnipeg Calcitonin in Quebec City Calcitonin in Hamilton Calcitonin in Kitchener Calcitonin in London Calcitonin in Halifax Calcitonin in New York Calcitonin in Los Angeles Calcitonin in Chicago Calcitonin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease